can glp 1 cause muscle weakness Balancing weight and loss in GLP1 receptor agonist therapy The Influence of Glucagon-like Peptide-1

V., Kondrakhin, E

The regimen may be changed or stopped if the therapy isnt working by weeks 8 to 12, if the patient has a new medical condition, or if side effects become bothersome

Interestingly, a study that did implement this titration approach found during the maintenance phase, rats treated with semaglutide showed a unexpected marked increase in the intake of lower concentrations of sucrose compared to vehicle treated controls, despite continuing to consume chow at only 90% the level of vehicle-treated animals (Cawthon et al., 2023)

10.1038/s43856-023-00242-8 10 BaliouS.AdamakiM.IoannouP.PappaA.PanayiotidisM